SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Director/PDMR Shareholding

10 Feb 2023 14:12

RNS Number : 6220P
Victrex PLC
10 February 2023
Β 

10 February 2023

Victrex plc (the Company)

Grant of Options under the Victrex plc 2015 UK Sharesave Plan

Notification of transactions by directors/persons discharging managerial responsibilities

Victrex plc announces that it has launched two 2023 Save As You Earn Schemes (the "SAYE Scheme"). The SAYE Scheme is an all-employee scheme which gives the opportunity to eligible UK employees to acquire shares at a discount, over 3 or 5 years.

Eligible employees were invited to subscribe for options over the Company's ordinary shares of 1p each ("Shares"), with an exercise price of Β£13.936 per share representing a 20% discount to the closing mid-market price on 11 January 2023, the day before the invitation to participate was made. The exercise price was calculated in accordance with the rules of the SAYE. The options have a savings start date of 1 April 2023 and will normally be exercisable for 6 month period commencing 1 April 2026 for the 3 Year contract, and 1 April 2028 for the 5 Year contract.

A total of 463 employees elected to participate in the 2023 SAYE Scheme accordingly a total of 374,055 options were granted on 9 February 2023. In consideration of these options, the grantees will make monthly savings during the associated savings contract.

The following Persons Discharging Managerial Responsibility ("PDMRs") have chosen to participate in the 2023 SAYE Scheme:

Name

Position

No. of shares under options granted

Savings Contract Period

Jakob Sigurdsson

Executive Director

2,152

5 Years

Martin Court

Executive Director

645

3 Years

Ian Melling

Executive Director

1,291

3 Years

Β 

The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation is appended below and gives further details on the option grants for directors and PDMRs.

Β Β 

Β 

Β 

Β 

Β 

Β 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

1. Β Jakob Sigurdsson

2. Β Martin Court

3. Β Ian Melling

2

Reason for the notification

a)

Position/status

Executive Director (PDMR)

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Victrex plc

b)

LEI

213800UYNPHAUNHPXL67

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Option over ordinary shares of 1p each

Β 

Β 

GB0009292243

b)

Nature of the transaction

Option granted under the Company's all-employee HMRC approved Save As You Earn scheme (Victrex plc 2015 UK Sharesave Plan) with an exercise price of Β£13.936.

c)

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

1.

Β£13.936

2,152

2.

Β£13.936

645

3.

Β£13.936

1,291

Β 

d)

Aggregated information

- Aggregated volume

- Price

Β 

N/A

N/A

Β 

e)

Date of the transaction

9 February 2023

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHMZGMZDGMGFZM
Date   Source Headline
29th May 202611:00 amRNSTotal Voting Rights
18th May 20268:50 amRNSDirectorate change
11th May 20267:00 amRNSHalf-year Financial Report
30th Apr 202610:46 amRNSTotal Voting Rights
29th Apr 20264:28 pmRNSHolding(s) in Company
31st Mar 20261:37 pmRNSTotal Voting Rights
24th Mar 20264:29 pmRNSHolding(s) in Company
24th Mar 20262:03 pmRNSHolding(s) in Company
20th Mar 20269:38 amRNSHolding(s) in Company
27th Feb 20262:40 pmRNSTotal Voting Rights
27th Feb 20261:02 pmRNSHolding(s) in Company
24th Feb 202611:41 amRNSHolding(s) in Company
17th Feb 20263:06 pmRNSDirector/PDMR Shareholding
12th Feb 20263:26 pmRNSDirector/PDMR Shareholding
12th Feb 20263:22 pmRNSDirector/PDMR Shareholding
10th Feb 20262:43 pmRNSDirector/PDMR Shareholding
10th Feb 20269:00 amRNSDirectorate change
6th Feb 20261:33 pmRNSResult of AGM
6th Feb 20267:00 amRNSQ1 Trading Update
30th Jan 202611:49 amRNSTotal Voting Rights
28th Jan 202612:25 pmRNSHolding(s) in Company
22nd Jan 202610:21 amRNSHolding(s) in Company
20th Jan 20261:26 pmRNSAdditional Listing
31st Dec 20259:00 amRNSTotal Voting Rights
31st Dec 20259:00 amRNSTotal Voting Rights
22nd Dec 202512:00 pmRNSAnnual Financial Report
22nd Dec 202512:00 pmRNSAnnual Financial Report
18th Dec 202511:49 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20253:42 pmRNSDirector/PDMR Shareholding
17th Dec 202512:08 pmRNSDirector/PDMR Shareholding
15th Dec 20259:00 amRNSDirector/PDMR Shareholding
11th Dec 20258:52 amRNSDirector/PDMR Shareholding
5th Dec 20259:30 amRNSShare purchase by incoming Director (incoming CEO)
4th Dec 20259:06 amRNSFinancial Calendar Update
2nd Dec 20257:00 amRNSPreliminary Results
1st Dec 202510:49 amRNSBlock listing Interim Review
28th Nov 20259:27 amRNSTotal Voting Rights
20th Nov 20259:05 amRNSAdditional Listing
7th Nov 202510:39 amRNSHolding(s) in Company
31st Oct 20258:58 amRNSTotal Voting Rights
21st Oct 20257:30 amRNSCEO Succession update
3rd Oct 202511:36 amRNSHolding(s) in Company
3rd Oct 20259:03 amRNSHolding(s) in Company
30th Sep 20259:54 amRNSTotal Voting Rights
29th Aug 202510:16 amRNSTotal Voting Rights
31st Jul 20259:14 amRNSTotal Voting Rights
9th Jul 20251:02 pmRNSHolding(s) in Company
8th Jul 20253:33 pmRNSDirector/PDMR Shareholding
8th Jul 20257:00 amRNSDirectorate change: CEO succession
8th Jul 20257:00 amRNSQ3 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.